Global Angioplasty Balloons Market Is Estimated To Witness Growing Incidences Of Minimal Invasive Surgery And Growing Population

 

Angioplasty Balloons Market
Angioplasty Balloons Market


Overview:

Angioplasty is often used to treat coronary artery disease, which is the hardening of the arteries that supply blood to the heart. This condition is caused by a build-up of fatty deposits, called plaques, on the artery walls. A catheter with a small balloon is inserted into a blocked blood vessel (an artery) using an incision in the wrist or groin. The doctor inflates the balloon to widen the blood vessel, squashing fatty deposits against the artery wall so blood can flow through more freely. To help keep the artery open, a short wire mesh tube called a stent may also be placed during the procedure. Stents are usually coated with a medication that helps prevent the artery from narrowing again after angioplasty.

Market Dynamics:

Growing technological advancements are estimated to augment growth of the global angioplasty balloons market over the forecast period. For instance, Cardiovascular Systems declared the availability of OrbusNeich JADE PTA over wire catheters in the United States of America in June 2021. Moreover, lack of awareness is anticipated to restrain growth of the global angioplasty balloons market over the forecast period.

Impact of COVID-19:

The pandemic was announced as a public health emergency in 2020 by the World Health Organization. The pandemic had long-term effects on several businesses around the world. The pandemic affected almost every country and the world economy. It had a major impact o on the healthcare sector. As the number of COVID-19 cases were increasing, healthcare professionals were prioritizing those patients. This led to delay in treatment of many cardiovascular diseases. Manufacturers of these devices were also facing issues owing to strict lockdowns and shortage of raw materials. This had a negative impact on the growth of the global angioplasty balloons market.

Key Takeaways:

The global angioplasty balloons market is expected to witness high growth, exhibiting CAGR of 8.3 % over the forecast period, due to increasing product approvals. For instance, BrosMed Medical gained 510(k) clearance from the U.S. FDA in July 2022, for their Tiche 0.035 PTA Balloon Dilation Catheter.

North America is anticipated to witness significant growth in the global angioplasty balloons market over the forecast period, owing to growing healthcare expenditure and increasing presence of key players.

Major players operating in the global angioplasty balloons market are Terumo Corporation, Medtronic, Teleflex Incororated, Boston Scientific Corporation, Stryker, Abbott, Panmed US, AngioDynamics, Palex Medical SA, B. Braun Melsungen AG., Nipro Medical Corporation, Biomerics, MicroPort Scientific Corporation, BIOTRONIK Vertriebs GmbH & Co. KG, Koninklijke Philips N.V.., Cook, CTK biotech, Inc, Cardinal Health, and JOTEC GmbH.

 

Comments

Popular posts from this blog

Rising Cancer Cases to boost the Molecular Cytogenetics Market Growth

Bispecific Antibodies Are Used As Therapeutic Drugs While Treating Viral Infections, Oncology, And Auto-Immune Diseases

Organic Milk Has Much Higher Concentration Of Iron, Vitamin E, And Polyunsaturated Fatty Acids Omega-3 And Omega-6 As Compared To Regular Milk